NCT06797908 Systemic Arterial Hypertension in Pediatric Age.
| NCT ID | NCT06797908 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2020-10-13 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2020-10-13 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We decided to conduct this study because hypertension in childhood increases the risk of developing cardiovascular disease (such as heart attack or stroke) in adulthood, beginning to damage important structures and organs, such as blood vessels, heart, and kidneys, from an early age. There is a clear need to identify those at greatest risk of developing hypertension as early as possible and to follow them appropriately. The main objectives of the study are to describe the causes of hypertension, study the clinical-laboratory features in the patient with hypertension (such as associated symptoms or conditions, or altered blood test values), evaluate the possible involvement of the heart, and describe the overall approach to the patient with hypertension, from diagnosis (i.e., identification of the condition) to treatment.
Eligibility Criteria
Inclusion Criteria: * Patients younger than 18 years of age with hypertension and normal-high blood pressure Exclusion Criteria: * Patients with normal blood pressure values
Contact & Investigator
Marianna Fabi, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06797908 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06797908 currently recruiting?
Yes, NCT06797908 is actively recruiting participants. Contact the research team at marianna.fabi@aosp.bo.it for enrollment information.
Where is the NCT06797908 trial being conducted?
This trial is being conducted at Bologna, Italy, Bologna, Italy, Bologna, Italy.
Who is sponsoring the NCT06797908 clinical trial?
NCT06797908 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Marianna Fabi, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 350 participants.